HeartBeam is transforming cardiac care through the power of personalized insights

Illustration of a Mans Chest where the ECG is recorded

Simplifying access to intelligent and actionable 12-lead ECGs*

HeartBeam's groundbreaking approach offers a holistic view of heart health by capturing the heart's electrical activity from three dimensions (X,Y and Z signals) for  actionable heart intelligence. This unique approach delivers exceptional data fidelity through a portable, cable-free device* that can be used by patients wherever they are when symptoms occur to capture signals without the need for trained professionals.

In the future, HeartBeam will be able to synthesize the signals into a 12-lead ECG using a personalized transformation matrix. The ease of use will simplify access and shorten the time to receive valuable 12-lead ECG results, especially upon symptom onset, when minutes matter the most.

Additionally, by leveraging artificial intelligence (AI) to analyze the data-rich signals, HeartBeam will be able to improve diagnostic accuracy, track cardiac trends over time, and detect subtle changes that could signal early warning signs. Through the power of AI, HeartBeam has the potential to deliver earlier and more precise management of heart health.

The concept for HeartBeam’s technology was created by Dr. Branislav Vajdic, the co-inventor of flash memory, in collaboration with a Harvard-Beth Israel cardiologist and two nuclear physicists. The technology is well protected with 13 US patents and can be used as a platform technology with broad applications including use in extended wear patches, watches, continuous monitoring systems and with deep learning solutions.

*Product not cleared by the FDA. Not available for sale in the United States.

The Future of Cardiac Care

By applying artificial intelligence (AI) to data-rich signals, HeartBeam will be able to provide physicians with unprecedented diagnostic and prognostic insights, including:
Detection of complex arrhythmias and heart attacks*
Personalized cardiac insights through multiple readings captured over time
Predict declining cardiac health and manage chronic conditions
Replace 12-lead ECGs as standard of care
*Ischemia product not cleared by FDA.  Not available for sale in the United States.

Heart Attack Detection*

A study published in JACC: Advances7 comparing HeartBeam’s technology to standard 12-lead ECGs found that HeartBeam is:

Equivalent to 12-lead ECG in identifying coronary occlusions

Highly accurate (AUC)

*Ischemia product not cleared by FDA.  Not available for sale in the United States.

Latest Data

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
View the HRS Presentation
Positive Results on HeartBeam's Artificial Intelligence Capabilities Demonstrate HeartBeam AI Combined with VCG Greatly Improves Detection of Atrial Flutter Over Single-Lead ECGs
Read the EHRA Abstract

Latest Data

Positive Results on HeartBeam's Artificial Intelligence Capabilities Demonstrate HeartBeam AI Combined with VCG Greatly Improves Detection of Atrial Flutter Over Single-Lead ECGs.
Read the EHRA Abstract
=